Litcius/Paper detail

Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil

Camila Dermínio Donadel, Gil Cunha De Santis, Thiago E. Gonçalves, Bruno Garcia Pires, Leonardo Carvalho Palma, Flavia Gava, Renato Luiz Guerino-Cunha, Joana T B Faria, Gabriela V. Silva, Luiz Guilherme Darrigo, Giancarlo Fatobene, Vanderson Rocha, Dimas Tadeu Covas, Rodrigo T. Calado, Diego V. Clé

2024Bone Marrow Transplantation10 citationsDOI

Topics & Concepts

MedicineLymphoblastic LeukemiaRefractory (planetary science)LymphomaLymphoblastic lymphomaAcute lymphocytic leukemiaOncologyLeukemiaCD19Internal medicineCancer researchImmunologyT cellAntigenAstrobiologyPhysicsImmune systemCAR-T cell therapy research
Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil | Litcius